Involvement of E2F transcription factor family in cancer

European Journal of Cancer

Volumn 41, Issue 16, 2005, Pages 2403-2414

  Tsantoulis, P K ^a   Gorgoulis, V G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Apoptosis; Bladder tumours; Breast tumours; Cancer; Cell cycle; DNA damage; E2F transcription factors; E2F1 transcription factor; Lung cancer; Transcription factors

Indexed keywords

ADENOVIRUS VECTOR; DNA; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; TRANSCRIPTION FACTOR E2F6;

APOPTOSIS; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CELL LINE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; GENE MUTATION; GENE TARGETING; GENOMIC INSTABILITY; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

EID: 27544431579     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.08.005     Document Type: Article

References (179)

1. S. Chiang, J. Azizkhan, and T. Beerman A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression Biochemistry 37 9 1998 3109 3115
2. L. Mallucci, V. Wells, and A. Danikas Turning cell cycle controller genes into cancer drugs. A role for an antiproliferative cytokine (betaGBP) Biochem Pharmacol 66 8 2003 1563 1569
3. I. Kovesdi, R. Reichel, and J. Nevins Identification of a cellular transcription factor involved in E1A trans-activation Cell 45 2 1986 219 228
4. N.L. Thangue, and P. Rigby An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells Cell 49 4 1987 507 513
5. S. Bagchi, P. Raychaudhuri, and J. Nevins Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation Cell 62 4 1990 659 669
6. A. de Bruin, B. Maiti, and L. Jakoi Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation J Biol Chem 278 43 2003 42041 42049
7. N. Logan, L. Delavaine, and A. Graham E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains Oncogene 23 30 2004 5138 5150
8. B. Maiti, J. Li, and A. deBruin Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation J Biol Chem 2005
9. H. Müller, M. Moroni, and E. Vigo Induction of S-phase entry by E2F transcription factors depends on their nuclear localization Mol Cell Biol 17 9 1997 5508 5520
10. G. Leone, F. Nuckolls, and S. Ishida Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins Mol Cell Biol 20 10 2000 3626 3632
11. R. Verona, K. Moberg, and S. Estes E2F activity is regulated by cell cycle-dependent changes in subcellular localization Mol Cell Biol 17 12 1997 7268 7282
12. D. Johnson, J. Schwarz, and W. Cress Expression of transcription factor E2F1 induces quiescent cells to enter S phase Nature 365 6444 1993 349 352
13. X. Qin, D. Livingston, and W. Kaelin Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis Proc Natl Acad Sci USA 91 23 1994 10918 10922
14. J. DeGregori, G. Leone, and A. Miron Distinct roles for E2F proteins in cell growth control and apoptosis Proc Natl Acad Sci USA 94 14 1997 7245 7250
15. J. Lukas, B. Petersen, and K. Holm Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression Mol Cell Biol 16 3 1996 1047 1057
16. L. Fajas, R.L. Landsberg, and Y. Huss-Garcia E2Fs regulate adipocyte differentiation Dev Cell 3 1 2002 39 49
17. R.L. Landsberg, J.E. Sero, and P.S. Danielian The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity Proc Natl Acad Sci USA 100 5 2003 2456 2461
18. P. Humbert, C. Rogers, and S. Ganiatsas E2F4 is essential for normal erythrocyte maturation and neonatal viability Mol Cell 6 2 2000 281 291
19. M. Morkel, J. Wenkel, and A. Bannister An E2F-like repressor of transcription Nature 390 6660 1997 567 568
20. P. Cartwright, H. Müller, and C. Wagener E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription Oncogene 17 5 1998 611 623
21. J. Trimarchi, B. Fairchild, and J. Wen The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex Proc Natl Acad Sci USA 98 4 2001 1519 1524
22. R. Girling, J. Partridge, and L. Bandara A new component of the transcription factor DRTF1/E2F Nature 362 6415 1993 83 87
23. Y. Zhang, and S. Chellappan Cloning and characterization of human DP2, a novel dimerization partner of E2F Oncogene 10 11 1995 2085 2093
24. E. Ormondroyd, S. de la Luna, and N.L. Thangue A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F Oncogene 11 8 1995 1437 1446
25. C. Wu, L. Zukerberg, and C. Ngwu In vivo association of E2F and DP family proteins Mol Cell Biol 15 5 1995 2536 2546
26. K. Rogers, P. Higgins, and M. Milla DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo Proc Natl Acad Sci USA 93 15 1996 7594 7599
27. L. Bandara, V. Buck, and M. Zamanian Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F EMBO J 12 11 1993 4317 4324
28. W. Krek, D. Livingston, and S. Shirodkar Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members Science 262 5139 1993 1557 1560
29. S. de la Luna, M. Burden, and C. Lee Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal J Cell Sci 109 Pt 10 1996 2443 2452
30. J. Magae, C. Wu, and S. Illenye Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members J Cell Sci 109 Pt 7 1996 1717 1726
31. D. Wang, J. Russell, and H. Xu Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis Mol Carcinog 31 2 2001 90 100
32. H. Müller, A. Bracken, and R. Vernell E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis Genes Dev 15 3 2001 267 285
33. J. Slansky, Y. Li, and W. Kaelin A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter Mol Cell Biol 13 3 1993 1610 1618
34. K. Hsiao, S. McMahon, and P. Farnham Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter Genes Dev 8 13 1994 1526 1537
35. C. Sardet, M. Vidal, and D. Cobrinik E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle Proc Natl Acad Sci USA 92 6 1995 2403 2407
36. S. Lin, A. Black, and D. Kostic Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction Mol Cell Biol 16 4 1996 1668 1675
37. J. Karlseder, H. Rotheneder, and E. Wintersberger Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F Mol Cell Biol 16 4 1996 1659 1667
38. A. Black, and J. Azizkhan-Clifford Regulation of E2F: a family of transcription factors involved in proliferation control Gene 237 2 1999 281 302
39. M. Campanero, M. Armstrong, and E. Flemington CpG methylation as a mechanism for the regulation of E2F activity Proc Natl Acad Sci USA 97 12 2000 6481 6486
40. M. Classon, and E. Harlow The retinoblastoma tumour suppressor in development and cancer Nat Rev Cancer 2 12 2002 910 917
41. L. Zhu, S. van den Heuvel, and K. Helin Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein Genes Dev 7 7A 1993 1111 1125
42. D. Cobrinik, P. Whyte, and D.S. Peeper Cell cycle-specific association of E2F with the p130 E1A-binding protein Genes Dev 7 12A 1993 2392 2404
43. X. Qin, T. Chittenden, and D. Livingston Identification of a growth suppression domain within the retinoblastoma gene product Genes Dev 6 6 1992 953 964
44. J. Lukas, D. Parry, and L. Aagaard Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 6531 1995 503 506
45. D. Cobrinik, M. Lee, and G. Hannon Shared role of the pRB-related p130 and p107 proteins in limb development Genes Dev 10 13 1996 1633 1644
46. M. Lipinski, and T. Jacks The retinoblastoma gene family in differentiation and development Oncogene 18 55 1999 7873 7882
47. M. Paggi, and A. Giordano Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother Cancer Res 61 12 2001 4651 4654
48. R. Ferreira, L. Magnaghi-Jaulin, and P. Robin The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase Proc Natl Acad Sci USA 95 18 1998 10493 10498
49. L. Magnaghi-Jaulin, R. Groisman, and I. Naguibneva Retinoblastoma protein represses transcription by recruiting a histone deacetylase Nature 391 6667 1998 601 605
50. S. Chellappan, S. Hiebert, and M. Mudryj The E2F transcription factor is a cellular target for the RB protein Cell 65 6 1991 1053 1061
51. B. Shan, X. Zhu, and P. Chen Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F Mol Cell Biol 12 12 1992 5620 5631
52. K. Helin, E. Harlow, and A. Fattaey Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein Mol Cell Biol 13 10 1993 6501 6508
53. J. Lees, M. Saito, and M. Vidal The retinoblastoma protein binds to a family of E2F transcription factors Mol Cell Biol 13 12 1993 7813 7825
54. T. Farkas, K. Hansen, and K. Holm Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4 J Biol Chem 277 30 2002 26741 26752
55. A. Brehm, E. Miska, and D. McCance Retinoblastoma protein recruits histone deacetylase to repress transcription Nature 391 6667 1998 597 601
56. N. Dyson The regulation of E2F by pRB-family proteins Genes Dev 12 15 1998 2245 2262
57. O. Stevaux, and N.J. Dyson A revised picture of the E2F transcriptional network and RB function Curr Opin Cell Biol 14 6 2002 684 691
58. E. Neuman, E.K. Flemington, and W.R. Sellers Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter Mol Cell Biol 14 10 1994 6607 6615
59. K. Araki, Y. Nakajima, and K. Eto Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter Oncogene 22 48 2003 7632 7641
60. R. Sears, K. Ohtani, and J.R. Nevins Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals Mol Cell Biol 17 9 1997 5227 5235
61. M.R. Adams, R. Sears, and F. Nuckolls Complex transcriptional regulatory mechanisms control expression of the E2F3 locus Mol Cell Biol 20 10 2000 3633 3639
62. G. Leone, J. DeGregori, and R. Sears Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F Nature 387 6631 1997 422 426
63. G. Leone, R. Sears, and E. Huang Myc requires distinct E2F activities to induce S phase and apoptosis Mol Cell 8 1 2001 105 113
64. R. Fagan, K. Flint, and N. Jones Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein Cell 78 5 1994 799 811
65. D. Peeper, P. Keblusek, and K. Helin Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro Oncogene 10 1 1995 39 48
66. L. Vandel, and T. Kouzarides Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase EMBO J 18 15 1999 4280 4291
67. W. Lin, F. Lin, and J. Nevins Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation Genes Dev 15 14 2001 1833 1844
68. B. Wang, K. Liu, and F.T. Lin A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis J Biol Chem 279 52 2004 54140 54152
69. M. Campanero, and E. Flemington Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumour suppressor protein Proc Natl Acad Sci USA 94 6 1997 2221 2226
70. F. Martelli, T. Hamilton, and D. Silver p19 ARF targets certain E2F species for degradation Proc Natl Acad Sci USA 98 8 2001 4455 4460
71. G. Dimri, K. Itahana, and M. Acosta Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14 (ARF) tumour suppressor Mol Cell Biol 20 1 2000 273 285
72. T. Ohta, and Y. Xiong Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases Cancer Res 61 4 2001 1347 1353
73. G. Marzio, C. Wagener, and M. Gutierrez E2F family members are differentially regulated by reversible acetylation J Biol Chem 275 15 2000 10887 10892
74. M. Martínez-Balbás, U. Bauer, and S. Nielsen Regulation of E2F1 activity by acetylation EMBO J 19 4 2000 662 671
75. J. Kato, H. Matsushime, and S.W. Hiebert Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 Genes Dev 7 3 1993 331 342
76. A.S. Lundberg, and R.A. Weinberg Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes Mol Cell Biol 18 2 1998 753 761
77. D. Tedesco, J. Lukas, and S.I. Reed The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF (Skp2) Genes Dev 16 22 2002 2946 2957
78. S. Bhattacharya, J. Garriga, and J. Calbó SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells Oncogene 22 16 2003 2443 2451
79. G. Lindeman, S. Gaubatz, and D. Livingston The subcellular localization of E2F-4 is cell-cycle dependent Proc Natl Acad Sci USA 94 10 1997 5095 5100
80. X. Wu, and A. Levine p53 and E2F-1 cooperate to mediate apoptosis Proc Natl Acad Sci USA 91 9 1994 3602 3606
81. T. Kowalik, J. DeGregori, and G. Leone E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2 Cell Growth Differ 9 2 1998 113 118
82. T.C. Hallstrom, and J.R. Nevins Specificity in the activation and control of transcription factor E2F-dependent apoptosis Proc Natl Acad Sci USA 100 19 2003 10848 10853
83. S. Bates, A. Phillips, and P. Clark p14ARF links the tumour suppressors RB and p53 Nature 395 6698 1998 124 125
84. K. Robertson, and P. Jones The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53 Mol Cell Biol 18 11 1998 6457 6473
85. K.Y. Tsai, D. MacPherson, and D.A. Rubinson ARF is not required for apoptosis in Rb mutant mouse embryos Curr Biol 12 2 2002 159 163
86. H.A. Rogoff, M.T. Pickering, and M.E. Debatis E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis Mol Cell Biol 22 15 2002 5308 5318
87. D. Tolbert, X. Lu, and C. Yin p19 (ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumour suppression in vivo Mol Cell Biol 22 1 2002 370 377
88. M.S. Lindstrœm, and K.G. Wiman Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts Oncogene 22 32 2003 4993 5005
89. A. Aslanian, P.J. Iaquinta, and R. Verona Repression of the Arf tumour suppressor by E2F3 is required for normal cell cycle kinetics Genes Dev 18 12 2004 1413 1422
90. J.T. Powers, S. Hong, and C.N. Mayhew E2F1 uses the ATM signalling pathway to induce p53 and Chk2 phosphorylation and apoptosis Mol Cancer Res 2 4 2004 203 214
91. H.A. Rogoff, M.T. Pickering, and F.M. Frame Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2 Mol Cell Biol 24 7 2004 2968 2977
92. J.K. Hsieh, D. Yap, and D.J. O'Connor Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage Mol Cell Biol 22 1 2002 78 93
93. T. Hershko, M. Chaussepied, and M. Oren Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F Cell Death Differ 12 4 2005 377 383
94. M. Moroni, E. Hickman, and E. Denchi Apaf-1 is a transcriptional target for E2F and p53 Nat Cell Biol 3 6 2001 552 558
95. Z. Guo, S. Yikang, and H. Yoshida Inactivation of the retinoblastoma tumour suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis Cancer Res 61 23 2001 8395 8400
96. T. Stiewe, and B. Pützer Role of the p53-homologue p73 in E2F1-induced apoptosis Nat Genet 26 4 2000 464 469
97. Y. Furukawa, N. Nishimura, and Y. Furukawa Apaf-1 is a mediator of E2F-1-induced apoptosis J Biol Chem 277 42 2002 39760 39768
98. R.S. Seelan, M. Irwin, and P. van der Stoop The human p73 promoter: characterization and identification of functional E2F binding sites Neoplasia 4 3 2002 195 203
99. Z. Nahle, J. Polakoff, and R.V. Davuluri Direct coupling of the cell cycle and cell death machinery by E2F Nat Cell Biol 4 11 2002 859 864
100. T. Hershko, and D. Ginsberg Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis J Biol Chem 279 10 2004 8627 8634
101. A. Phillips, M. Ernst, and S. Bates E2F-1 potentiates cell death by blocking antiapoptotic signalling pathways Mol Cell 4 5 1999 771 781
102. N.M. Wikonkal, E. Remenyik, and D. Knezevic Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice Nat Cell Biol 5 7 2003 655 660
103. N.B.L. Thangue The yin and yang of E2F-1: balancing life and death Nat Cell Biol 5 7 2003 587 589
104. M.B. Kastan, and J. Bartek Cell-cycle checkpoints and cancer Nature 432 7015 2004 316 323
105. C. Stevens, L. Smith, and N.B.L. Thangue Chk2 activates E2F-1 in response to DNA damage Nat Cell Biol 5 5 2003 401 409
106. J. Bartkova, Z. Horejsí, and K. Koed DNA damage response as a candidate anti-cancer barrier in early human tumourigenesis Nature 434 7035 2005 864 870
107. Y. Huang, T. Ishiko, and S. Nakada Role for E2F in DNA damage-induced entry of cells into S phase Cancer Res 57 17 1997 3640 3643
108. M. Hœfferer, C. Wirbelauer, and B. Humar Increased levels of E2F-1-dependent DNA binding activity after UV- or gamma-irradiation Nucleic Acids Res 27 2 1999 491 495
109. C. Blattner, A. Sparks, and D. Lane Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53 Mol Cell Biol 19 5 1999 3704 3713
110. D. O'Connor, and X. Lu Stress signals induce transcriptionally inactive E2F-1 independently of p53 and Rb Oncogene 19 20 2000 2369 2376
111. N. Pediconi, A. Ianari, and A. Costanzo Differential regulation of E2F1 apoptotic target genes in response to DNA damage Nat Cell Biol 5 6 2003 552 558
112. P.O. Humbert, R. Verona, and J.M. Trimarchi E2f3 is critical for normal cellular proliferation Genes Dev 14 6 2000 690 703
113. Z.M. Wang, H. Yang, and D.M. Livingston Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts Proc Natl Acad Sci USA 95 26 1998 15583 15586
114. J.E. Cloud, C. Rogers, and T.L. Reza Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo Mol Cell Biol 22 8 2002 2663 2672
115. D. Johnson, W. Cress, and L. Jakoi Oncogenic capacity of the E2F1 gene Proc Natl Acad Sci USA 91 26 1994 12823 12827
116. J. Schwarz, C. Bassing, and I. Kovesdi Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression Proc Natl Acad Sci USA 92 2 1995 483 487
117. A. Pierce, I. Gimenez-Conti, and R. Schneider-Broussard Increased E2F1 activity induces skin tumours in mice heterozygous and nullizygous for p53 Proc Natl Acad Sci USA 95 15 1998 8858 8863
118. A. Pierce, S. Fisher, and C. Conti Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumour development Oncogene 16 10 1998 1267 1276
119. A. Pierce, R. Schneider-Broussard, and I. Gimenez-Conti E2F1 has both oncogenic and tumour-suppressive properties in a transgenic model Mol Cell Biol 19 9 1999 6408 6414
120. E.A. Conner, E.R. Lemmer, and M. Omori Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis Oncogene 19 44 2000 5054 5062
121. B. Scheijen, M. Bronk, and T. van der Meer High incidence of thymic epithelial tumours in E2F2 transgenic mice J Biol Chem 279 11 2004 10476 10483
122. L. Yamasaki, T. Jacks, and R. Bronson Tumour induction and tissue atrophy in mice lacking E2F-1 Cell 85 4 1996 537 548
123. R.J. Rounbehler, P.M. Rogers, and C.J. Conti Inactivation of E2f1 enhances tumourigenesis in a Myc transgenic model Cancer Res 62 11 2002 3276 3281
124. U. Ziebold, E.Y. Lee, and R.T. Bronson E2F3 loss has opposing effects on different pRB-deficient tumours, resulting in suppression of pituitary tumours but metastasis of medullary thyroid carcinomas Mol Cell Biol 23 18 2003 6542 6552
125. U. Ziebold, T. Reza, and A. Caron E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos Genes Dev 15 4 2001 386 391
126. J.W. Zhu, S.J. Field, and L. Gore E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumourigenesis Mol Cell Biol 21 24 2001 8547 8564
127. F.X. Li, J.W. Zhu, and C.J. Hogan Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice Mol Cell Biol 23 10 2003 3607 3622
128. L. Yamasaki, R. Bronson, and B. Williams Loss of E2F-1 reduces tumourigenesis and extends the lifespan of Rb1 (+/-) mice Nat Genet 18 4 1998 360 364
129. E.Y. Lee, H. Cam, and U. Ziebold E2F4 loss suppresses tumourigenesis in Rb mutant mice Cancer Cell 2 6 2002 463 472
130. C.J. Sherr, and F. McCormick The RB and p53 pathways in cancer Cancer Cell 2 2 2002 103 112
131. V.G. Gorgoulis, P. Zacharatos, and G. Mariatos Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas J Pathol 198 2 2002 142 156
132. P. Karakaidos, S. Taraviras, and L.V. Vassiliou Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumour growth and chromosomal instability-evidence of E2F-1 transcriptional control over hCdt1 Am J Pathol 165 4 2004 1351 1365
133. M.A. Imai, Y. Oda, and M. Oda Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma J Cancer Res Clin Oncol 130 6 2004 320 326
134. S. Nicholson, N. Okby, and M. Khan Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma Cancer Res 61 14 2001 5636 5643
135. V.G. Gorgoulis, P. Zacharatos, and A. Kotsinas Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression Am J Pathol 153 6 1998 1749 1765
136. B. Eymin, S. Gazzeri, and C. Brambilla Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma Oncogene 20 14 2001 1678 1687
137. H. Kuhn, U. Liebers, and C. Gessner Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Eur Respir J 20 3 2002 703 709
138. J. Draus, M. Elliott, and C. Atienza p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells Exp Mol Med 33 4 2001 209 219
139. H. Yamamoto, J. Soh, and T. Monden Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis Clin Cancer Res 5 7 1999 1805 1815
140. A.D. Saiz, M. Olvera, and S. Rezk Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions J Pathol 198 2 2002 157 162
141. M. Onda, H. Nagai, and A. Yoshida Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers J Hum Genet 49 6 2004 312 318
142. K. Yamazaki, T. Yajima, and T. Nagao Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study Pathol Res Pract 199 1 2003 23 28
143. M. Kouvaraki, V.G. Gorgoulis, and G.Z. Rassidakis High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumours Cancer 94 9 2002 2454 2465
144. P. Zacharatos, A. Kotsinas, and K. Evangelou Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas J Pathol 203 3 2004 744 753
145. S. Zhang, S. Liu, and L. Al-Saleem E2F-1: a proliferative marker of breast neoplasia Cancer Epidemiol Biomark Prev 9 4 2000 395 401
146. S. Han, K. Park, and B.N. Bae E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide Breast Cancer Res Treat 82 1 2003 11 16
147. M. Kouvaraki, V. Gorgoulis, and G. Rassidakis Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumours Anticancer Res 21 2A 2001 991 999
148. D.F. Callen, J. Crawford, and C. Derwas Defining regions of loss of heterozygosity of 16q in breast cancer cell lines Cancer Genet Cytogenet 133 1 2002 76 82
149. E.A. Rakha, S.E. Pinder, and E.C. Paish Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis J Pathol 203 3 2004 754 761
150. J. Polanowska, L.L. Cam, and B. Orsetti Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumours Genes Chromosomes Cancer 28 1 2000 126 130
151. M. Macaluso, C. Cinti, and G. Russo pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer Oncogene 22 23 2003 3511 3517
152. F. Rabbani, V. Richon, and I. Orlow Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization J Natl Cancer Inst 91 10 1999 874 881
153. S.I. Baithun, M. Naase, and A. Blanes Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications Virchows Arch 438 3 2001 289 297
154. A. Feber, J. Clark, and G. Goodwin Amplification and overexpression of E2F3 in human bladder cancer Oncogene 23 8 2004 1627 1630
155. M. Oeggerli, S. Tomovska, and P. Schraml E2F3 amplification and overexpression is associated with invasive tumour growth and rapid tumour cell proliferation in urinary bladder cancer Oncogene 23 33 2004 5616 5623
156. J.A. Veltman, J. Fridlyand, and S. Pejavar Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumours Cancer Res 63 11 2003 2872 2880
157. J. Bramis, P. Zacharatos, and I. Papaconstantinou E2F-1 transcription factor immunoexpression is inversely associated with tumour growth in colon adenocarcinomas Anticancer Res 24 5A 2004 3041 3047
158. T. Suzuki, W. Yasui, and H. Yokozaki Expression of the E2F family in human gastrointestinal carcinomas Int J Cancer 81 4 1999 535 538
159. W. Yasui, J. Fujimoto, and T. Suzuki Expression of cell-cycle-regulating transcription factor E2F-1 in colorectal carcinomas Pathobiology 67 4 1999 174 179
160. M.B. Møller, P.W. Kania, and Y. Ino Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A Leukemia 14 5 2000 898 904
161. C. Postma, M. Hermsen, and J. Coffa Chromosomal instability in flat adenomas and carcinomas of the colon J Pathol 205 4 2005 514 521
162. H.H. Mady, S. Hasso, and M.F. Melhem Expression of E2F-4 gene in colorectal adenocarcinoma and corresponding covering mucosa: an immunohistochemistry, image analysis, and immunoblot study Appl Immunohistochem Mol Morphol 10 3 2002 225 230
163. R. Souza, J. Yin, and K. Smolinski Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumours Cancer Res 57 12 1997 2350 2353
164. X. Zhong, H. Hemmi, and J. Koike Various AGC repeat numbers in the coding region of the human transcription factor gene E2F-4 Hum Mutat 15 3 2000 296 297
165. S. Schwemmle, and G. Pfeifer Genomic structure and mutation screening of the E2F4 gene in human tumours Int J Cancer 86 5 2000 672 677
166. J.R. Nevins The Rb/E2F pathway and cancer Hum Mol Genet 10 7 2001 699 703
167. C.S. Foster, A. Falconer, and A.R. Dodson Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome Oncogene 23 35 2004 5871 5879
168. D.G. Bostwick, H.B. Burke, and D. Djakiew Human prostate cancer risk factors Cancer 101 Suppl. 10 2004 2371 2490
169. K. Hofman, J. Swinnen, and G. Verhoeven E2F activity is biphasically regulated by androgens in LNCaP cells Biochem Biophys Res Commun 283 1 2001 97 101
170. D. Agus, C. Cordon-Cardo, and W. Fox Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence J Natl Cancer Inst 91 21 1999 1869 1876
171. D. Hanahan, and R. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
172. V.G. Gorgoulis, L.V.F. Vassiliou, and P. Karakaidos Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 434 7035 2005 907 913
173. J. DeGregori The genetics of the E2F family of transcription factors: shared functions and unique roles Biochim Biophys Acta 1602 2 2002 131 150
174. S. Saxena, and A. Dutta Geminin-Cdt1 balance is critical for genetic stability Mutat Res 569 1-2 2005 111 121
175. K. Yoshida, and I. Inoue Regulation of Geminin and Cdt1 expression by E2F transcription factors Oncogene 23 21 2004 3802 3812
176. T. Kowalik, J. DeGregori, and J. Schwarz E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis J Virol 69 4 1995 2491 2500
177. A.G. Paulovich, D.P. Toczyski, and L.H. Hartwell When checkpoints fail Cell 88 3 1997 315 321
178. H.I. Saavedra, B. Maiti, and C. Timmers Inactivation of E2F3 results in centrosome amplification Cancer Cell 3 4 2003 333 346
179. W.G. Kaelin E2F1 as a target: promoter-driven suicide and small molecule modulators Cancer Biol Ther 2 4 Suppl. 1 2003 S48 S54